Switzer TV

This episode dives into a big week for investors as Wall Street waits to see if the US Federal Reserve will deliver a standard 25-basis-point rate cut—or surprise with a jumbo 50. We explore what that means for markets, Donald Trump’s pressure on Jerome Powell, and how currencies might shift.

We also look at opportunities in the stock market, from hospital operator Ramsay to tech players like Xero, NextDC, and WiseTech. Then we speak with Mark Cooksey, CEO of ABx, about the company’s rare earths projects in Tasmania, their clean fluorine chemicals partnership with Rio Tinto, and why their resource could be globally unique.

Finally, Luke Hopewell explains why Telstra and NBN Co just made internet speeds five times faster for Australian households—though apartment dwellers may miss out. Faster streaming, quicker uploads, and big implications for regional businesses all come into play.

Stay tuned for insights that could shape your portfolio

Switzer Investing TV | 15 September 2025: What would US rate cuts mean for your portfolio? PLUS: Rare earths surge, and so does your home internet speed

This episode dives into a big week for investors as Wall Street waits to see if the US Federal Reserve will deliver a standard 25-basis-point rate cut—or surprise with a jumbo 50. We explore what that means for markets, Donald Trump’s pressure on Jerome Powell, and how currencies might shift.

More videos

My knee replacement

Dr Ross Walker shares his own experience of having a total knee replacement.

Series: ,
Mad about Money Live

Tune in to find out the latest money and market news with Peter Switzer and Paul Rickard.

Series: ,
We pinpoint some tech stocks you don't want to ignore!

Peter Switzer is joined by Burman Invest's Julia Lee, Medallion's Michael Wayne, Tribeca's Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
The link between COVID-19 and heart disease

Dr Ross Walker looks at whether there is any connection between the Coronavirus and drugs used to treat cardiovascular disease.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
Is Mesoblast the biomedical stock you have to have? + Freelancer: stock on the way up?

Peter Switzer is joined by Burman Invest's Julia Lee, Freelancer.com's Matt Barrie, Vanguard's Robin Bowerman and Switzer's Paul Rickard.

Series: ,
What is a viral load?

Dr Ross Walker looks at viral load in relation to COVID-19 and which people are most at risk.

Series: ,
Mad about Money Live

Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.

Series: ,
Tech stocks on the slide! Which stocks are the best buys?

On this week's show, Peter Switzer is joined by Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, Tribeca Investment Partners' Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
How to boost your immunity

Dr Ross Walker explains how you can boost your immunity and which vitamins will give you an extra boost.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
7 Experts! Their One Best Stock! Plus, CEO of NextDC - Check Out The Future!

Peter Switzer talks to the experts about the best companies coming out of reporting season, plus NextDC CEO Craig Scroggie.

Series: ,
1 40 41 42 43 44 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram